Portfolio Holdings Detail for ISIN IE00BYZK4776
Stock Name / Fund iShares Healthcare Innovation UCITS ETF USD (Acc)
Issuer Blackrock
Entity holding fund iShares IV Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF Ticker DRDR(GBX) LSE
ETF Ticker 2B78(EUR) F
ETF Ticker 2B78.DE(EUR) CXE
ETF Ticker DRDR.LS(GBX) CXE
ETF Ticker HEAL.AS(EUR) CXE
ETF Ticker HEAL.LS(USD) CXE
ETF Ticker HEALz(USD) CXE
ETF Ticker HEAL(EUR) ETF Plus
ETF Ticker DRDR.L(GBP) LSE

Holdings detail for ACLX

Stock Name	Arcellx Inc
Ticker	ACLX(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US03940C1009

Show aggregate ACLX holdings

News associated with ACLX

Arcellx, Inc. (NASDAQ:ACLX) Receives $114.31 Consensus Target Price from Analysts: Shares of Arcellx, Inc. (NASDAQ:ACLX – Get Free Report) have been given an average recommendation of “Buy” by the fifteen research firms that are covering the firm, MarketBeat Ratings reports. Thirteen research analysts have rated the stock with a buy recommendation and two have given a strong buy recommendation to the company. The average twelve-month […] - 2025-08-20 02:08:54
Arcellx, Inc. (NASDAQ:ACLX) Shares Sold by Deutsche Bank AG: Deutsche Bank AG lowered its position in Arcellx, Inc. (NASDAQ:ACLX – Free Report) by 0.2% during the first quarter, HoldingsChannel.com reports. The institutional investor owned 343,694 shares of the company’s stock after selling 835 shares during the quarter. Deutsche Bank AG’s holdings in Arcellx were worth $22,546,000 as of its most recent SEC filing. A […] - 2025-08-14 04:59:07
Arcellx, Inc. (NASDAQ:ACLX) Shares Sold by Zurcher Kantonalbank Zurich Cantonalbank: Zurcher Kantonalbank Zurich Cantonalbank lowered its position in shares of Arcellx, Inc. (NASDAQ:ACLX – Free Report) by 2.6% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 9,579 shares of the company’s stock after selling 257 shares during the […] - 2025-08-07 05:16:57
Victory Capital Management Inc. Cuts Position in Arcellx, Inc. (NASDAQ:ACLX): Victory Capital Management Inc. lowered its stake in Arcellx, Inc. (NASDAQ:ACLX – Free Report) by 3.3% in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 178,110 shares of the company’s stock after selling 6,073 shares during the quarter. Victory Capital Management Inc.’s holdings in […] - 2025-07-24 05:04:49
Bank of New York Mellon Corp Lowers Position in Arcellx, Inc. (NASDAQ:ACLX): Bank of New York Mellon Corp lowered its holdings in Arcellx, Inc. (NASDAQ:ACLX – Free Report) by 0.5% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 143,617 shares of the company’s stock after selling 792 shares during the period. Bank […] - 2025-07-22 07:29:04
Allspring Global Investments Holdings LLC Grows Holdings in Arcellx, Inc. (NASDAQ:ACLX): Allspring Global Investments Holdings LLC raised its stake in Arcellx, Inc. (NASDAQ:ACLX – Free Report) by 54.0% during the first quarter, Holdings Channel reports. The fund owned 7,702 shares of the company’s stock after buying an additional 2,702 shares during the period. Allspring Global Investments Holdings LLC’s holdings in Arcellx were worth $468,000 as of […] - 2025-07-11 04:38:48
Arcellx (NASDAQ:ACLX) Coverage Initiated at Citigroup: Citigroup started coverage on shares of Arcellx (NASDAQ:ACLX – Get Free Report) in a report released on Tuesday, MarketBeat.com reports. The firm set a “buy” rating and a $110.00 price target on the stock. Citigroup’s price target suggests a potential upside of 72.36% from the company’s previous close. A number of other brokerages have also […] - 2025-06-19 02:26:48
Harbor Capital Advisors Inc. Sells 629 Shares of Arcellx, Inc. (NASDAQ:ACLX): Harbor Capital Advisors Inc. lessened its holdings in shares of Arcellx, Inc. (NASDAQ:ACLX – Free Report) by 2.7% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 22,836 shares of the company’s stock after selling 629 shares during the period. Harbor Capital Advisors Inc.’s holdings in Arcellx were […] - 2025-06-13 05:16:51
Squarepoint Ops LLC Sells 4,670 Shares of Arcellx, Inc. (NASDAQ:ACLX): Squarepoint Ops LLC cut its holdings in Arcellx, Inc. (NASDAQ:ACLX – Free Report) by 46.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 5,330 shares of the company’s stock after selling 4,670 shares during the period. Squarepoint Ops LLC’s holdings […] - 2025-06-06 05:14:57
Arcellx, Inc. (NASDAQ:ACLX) Receives $111.33 Average Target Price from Analysts: Shares of Arcellx, Inc. (NASDAQ:ACLX – Get Free Report) have received a consensus recommendation of “Buy” from the fourteen ratings firms that are currently covering the stock, MarketBeat.com reports. Thirteen investment analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 1 year […] - 2025-06-06 02:04:54
Two Sigma Advisers LP Purchases 1,100 Shares of Arcellx, Inc. (NASDAQ:ACLX): Two Sigma Advisers LP grew its holdings in shares of Arcellx, Inc. (NASDAQ:ACLX – Free Report) by 24.4% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 5,600 shares of the company’s stock after buying an additional 1,100 shares during the period. Two Sigma Advisers LP’s holdings in Arcellx were worth $429,000 as of […] - 2025-06-05 05:14:49
Millennium Management LLC Boosts Holdings in Arcellx, Inc. (NASDAQ:ACLX): Millennium Management LLC lifted its stake in Arcellx, Inc. (NASDAQ:ACLX – Free Report) by 123.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 22,370 shares of the company’s stock after purchasing an additional 12,370 shares during the quarter. Millennium […] - 2025-06-03 05:04:53
Nuveen Asset Management LLC Has $8.57 Million Stock Holdings in Arcellx, Inc. (NASDAQ:ACLX): Nuveen Asset Management LLC lowered its position in Arcellx, Inc. (NASDAQ:ACLX – Free Report) by 7.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 111,786 shares of the company’s stock after selling 9,110 shares during the period. Nuveen […] - 2025-05-29 04:54:51
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $2.10 Million Holdings in Arcellx, Inc. (NASDAQ:ACLX): MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in shares of Arcellx, Inc. (NASDAQ:ACLX – Free Report) by 6.2% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 27,363 shares of the company’s stock after purchasing an additional 1,589 shares during the quarter. MIRAE […] - 2025-05-22 05:51:03
Analysts Set Arcellx, Inc. (NASDAQ:ACLX) Price Target at $109.31: Shares of Arcellx, Inc. (NASDAQ:ACLX – Get Free Report) have earned an average recommendation of “Buy” from the fifteen ratings firms that are presently covering the company, MarketBeat.com reports. Thirteen analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. The average 1 year target […] - 2025-05-12 02:24:57
Dimensional Fund Advisors LP Acquires 186,013 Shares of Arcellx, Inc. (NASDAQ:ACLX): Dimensional Fund Advisors LP lifted its holdings in Arcellx, Inc. (NASDAQ:ACLX – Free Report) by 156.2% in the fourth quarter, Holdings Channel reports. The fund owned 305,088 shares of the company’s stock after purchasing an additional 186,013 shares during the quarter. Dimensional Fund Advisors LP’s holdings in Arcellx were worth $23,400,000 at the end of […] - 2025-05-07 05:22:53
Mariner LLC Increases Stake in Arcellx, Inc. (NASDAQ:ACLX): Mariner LLC grew its stake in Arcellx, Inc. (NASDAQ:ACLX – Free Report) by 37.8% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 6,980 shares of the company’s stock after purchasing an additional 1,915 shares during the period. Mariner LLC’s holdings […] - 2025-05-02 05:08:50
Invesco Ltd. Boosts Stake in Arcellx, Inc. (NASDAQ:ACLX): Invesco Ltd. boosted its stake in Arcellx, Inc. (NASDAQ:ACLX – Free Report) by 15.7% in the 4th quarter, Holdings Channel reports. The firm owned 26,550 shares of the company’s stock after purchasing an additional 3,610 shares during the period. Invesco Ltd.’s holdings in Arcellx were worth $2,036,000 at the end of the most recent quarter. […] - 2025-04-30 04:44:58
Renaissance Technologies LLC Takes $3.77 Million Position in Arcellx, Inc. (NASDAQ:ACLX): Renaissance Technologies LLC bought a new stake in Arcellx, Inc. (NASDAQ:ACLX – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 49,100 shares of the company’s stock, valued at approximately $3,765,000. Renaissance Technologies LLC owned approximately 0.09% of Arcellx at […] - 2025-04-23 05:27:02
Arcellx, Inc. (NASDAQ:ACLX) Shares Sold by Legal & General Group Plc: Legal & General Group Plc reduced its position in shares of Arcellx, Inc. (NASDAQ:ACLX – Free Report) by 3.2% in the 4th quarter, Holdings Channel.com reports. The firm owned 43,033 shares of the company’s stock after selling 1,402 shares during the period. Legal & General Group Plc’s holdings in Arcellx were worth $3,300,000 as of […] - 2025-04-23 05:26:58
Wellington Management Group LLP Sells 1,275 Shares of Arcellx, Inc. (NASDAQ:ACLX): Wellington Management Group LLP reduced its holdings in shares of Arcellx, Inc. (NASDAQ:ACLX – Free Report) by 6.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 19,693 shares of the company’s stock after selling 1,275 shares during the period. Wellington Management […] - 2025-04-14 04:44:59
Trexquant Investment LP Purchases Shares of 7,237 Arcellx, Inc. (NASDAQ:ACLX): Trexquant Investment LP acquired a new position in shares of Arcellx, Inc. (NASDAQ:ACLX – Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 7,237 shares of the company’s stock, valued at approximately $555,000. Other hedge funds have also made changes to their positions in the […] - 2025-04-13 06:00:57
Pictet Asset Management Holding SA Purchases 1,426 Shares of Arcellx, Inc. (NASDAQ:ACLX): Pictet Asset Management Holding SA grew its holdings in shares of Arcellx, Inc. (NASDAQ:ACLX – Free Report) by 40.5% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 4,945 shares of the company’s stock after buying an additional 1,426 shares during the period. Pictet Asset Management […] - 2025-04-10 05:37:03
Arcellx (NASDAQ:ACLX) Stock Price Down 6.8% After Insider Selling: Arcellx, Inc. (NASDAQ:ACLX – Get Free Report) traded down 6.8% during trading on Wednesday following insider selling activity. The company traded as low as $49.55 and last traded at $49.95. 248,582 shares changed hands during trading, a decline of 63% from the average session volume of 668,721 shares. The stock had previously closed at $53.60. […] - 2025-04-10 02:40:50
Arcellx, Inc. (NASDAQ:ACLX) Stock Holdings Lessened by Corebridge Financial Inc.: Corebridge Financial Inc. cut its stake in shares of Arcellx, Inc. (NASDAQ:ACLX – Free Report) by 7.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 21,430 shares of the company’s stock after selling 1,617 shares during the quarter. Corebridge […] - 2025-04-03 04:34:47
Thrivent Financial for Lutherans Has $5.33 Million Holdings in Arcellx, Inc. (NASDAQ:ACLX): Thrivent Financial for Lutherans increased its position in shares of Arcellx, Inc. (NASDAQ:ACLX – Free Report) by 44.0% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 69,461 shares of the company’s stock after purchasing an additional 21,221 shares during the period. Thrivent Financial for Lutherans’ holdings in Arcellx were worth $5,327,000 as […] - 2025-03-25 07:08:51
Analysts Forecast 35% Upside For FYX: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-03-13 09:48:08
Victory Capital Management Inc. Sells 43,236 Shares of Arcellx, Inc. (NASDAQ:ACLX): Victory Capital Management Inc. trimmed its stake in Arcellx, Inc. (NASDAQ:ACLX – Free Report) by 19.0% in the 4th quarter, Holdings Channel.com reports. The firm owned 184,183 shares of the company’s stock after selling 43,236 shares during the period. Victory Capital Management Inc.’s holdings in Arcellx were worth $14,125,000 at the end of the most […] - 2025-03-13 06:32:53
Analysts Set Arcellx, Inc. (NASDAQ:ACLX) PT at $105.93: Arcellx, Inc. (NASDAQ:ACLX – Get Free Report) has been assigned a consensus recommendation of “Buy” from the fifteen ratings firms that are currently covering the company, MarketBeat.com reports. Thirteen equities research analysts have rated the stock with a buy recommendation and two have assigned a strong buy recommendation to the company. The average 12-month target […] - 2025-02-27 04:22:50
Analysts Forecast 15% Upside For FSMD: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-02-10 10:37:37

iShares Healthcare Innovation UCITS ETF USD (Acc) ACLX holdings

Date	Number of ACLX Shares Held	Base Market Value of ACLX Shares	Local Market Value of ACLX Shares	Change in ACLX Base Value	Current Price per ACLX Share Held	Previous Price per ACLX Share Held
2025-11-11 (Tuesday)	50,562	USD 4,562,209	USD 4,562,209	USD 229,551	USD 90.23	USD 85.69
2025-11-10 (Monday)	50,562	USD 4,332,658	USD 4,332,658	USD -43,483	USD 85.69	USD 86.55
2025-11-07 (Friday)	50,562	USD 4,376,141	USD 4,376,141	USD -83,427	USD 86.55	USD 88.2
2025-11-06 (Thursday)	50,562	USD 4,459,568	USD 4,459,568	USD 34,887	USD 88.2	USD 87.51
2025-11-05 (Wednesday)	50,562	USD 4,424,681	USD 4,424,681	USD -33,876	USD 87.51	USD 88.18
2025-11-04 (Tuesday)	50,562	USD 4,458,557	USD 4,458,557	USD 103,652	USD 88.18	USD 86.13
2025-11-03 (Monday)	50,562	USD 4,354,905	USD 4,354,905	USD -208,316	USD 86.13	USD 90.25
2025-10-31 (Friday)	50,562	USD 4,563,221	USD 4,563,221	USD 139,046	USD 90.25	USD 87.5
2025-10-30 (Thursday)	50,562	USD 4,424,175	USD 4,424,175	USD 74,326	USD 87.5	USD 86.03
2025-10-29 (Wednesday)	50,562	USD 4,349,849	USD 4,349,849	USD -73,820	USD 86.03	USD 87.49
2025-10-28 (Tuesday)	50,562	USD 4,423,669	USD 4,423,669	USD 39,944	USD 87.49	USD 86.7
2025-10-27 (Monday)	50,562	USD 4,383,725	USD 4,383,725	USD 102,135	USD 86.7	USD 84.68

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of ACLX by Blackrock for IE00BYZK4776

Show aggregate share trades of ACLX

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-10-24 SELL -428 84.680 86.050 85.913 USD -36,771 71.51 Loss of -6,165 on sale
2025-09-11 BUY 215 77.680 77.690 77.689 USD 16,703 70.09
2025-07-08 SELL -214 66.560 67.330 67.253 USD -14,392 70.11 Profit of 611 on sale
2025-06-24 SELL -215 63.350 65.330 65.132 USD -14,003 70.40 Profit of 1,134 on sale
2025-06-23 SELL -215 63.620 63.710 63.701 USD -13,696 70.45 Profit of 1,452 on sale
2025-06-20 BUY 9,577 63.000 64.640 64.476 USD 617,487 70.51
2025-06-11 SELL -175 66.170 67.610 67.466 USD -11,807 70.82 Profit of 587 on sale
2025-05-30 SELL -176 62.060 63.870 63.689 USD -11,209 71.18 Profit of 1,318 on sale
2025-05-21 BUY 176 65.540 69.840 69.410 USD 12,216 71.64
2025-05-14 SELL -1,050 59.020 65.910 65.221 USD -68,482 72.09 Profit of 7,212 on sale
2025-04-30 SELL -175 64.950 65.850 65.760 USD -11,508 73.31 Profit of 1,321 on sale
2025-04-28 SELL -175 64.550 65.485 65.392 USD -11,444 73.48 Profit of 1,416 on sale
2025-04-25 SELL -175 63.710 64.170 64.124 USD -11,222 73.58 Profit of 1,655 on sale
2025-04-11 SELL -1,056 59.150 59.890 59.816 USD -63,166 74.61 Profit of 15,623 on sale
2025-04-08 SELL -528 53.600 58.860 58.334 USD -30,800 75.24 Profit of 8,924 on sale
2025-04-07 BUY 850 56.650 60.170 59.818 USD 50,845 75.45
2025-03-31 SELL -342 65.600 66.370 66.293 USD -22,672 76.06 Profit of 3,340 on sale
2025-03-21 SELL -342 69.330 71.280 71.085 USD -24,311 76.53 Profit of 1,862 on sale
2025-03-12 SELL -172 72.720 73.060 73.026 USD -12,560 77.03 Profit of 688 on sale
2025-02-28 SELL -172 64.820 65.370 65.315 USD -11,234 78.25 Profit of 2,224 on sale
2025-02-25 BUY 172 62.650 63.630 63.532 USD 10,928 79.12
2025-02-20 SELL -172 65.610 66.420 66.339 USD -11,410 79.94 Profit of 2,339 on sale
2025-02-19 BUY 344 63.290 64.585 64.455 USD 22,173 80.24
2025-02-18 BUY 172 64.255 67.000 66.725 USD 11,477 80.55
2024-12-30 BUY 749 78.350 79.120 79.043 USD 59,203 88.85
2024-12-06 SELL -166 84.550 89.000 88.555 USD -14,700 89.41 Profit of 142 on sale
2024-12-04 SELL -166 85.850 90.270 89.828 USD -14,911 89.65 Loss of -30 on sale
2024-12-03 SELL -332 88.650 96.390 95.616 USD -31,745 89.68 Loss of -1,970 on sale
2024-11-21 SELL -167 87.220 89.370 89.155 USD -14,889 89.55 Profit of 66 on sale
2024-11-20 SELL -169 87.220 88.300 88.192 USD -14,904 89.68 Profit of 252 on sale
2024-11-19 SELL -169 87.590 89.390 89.210 USD -15,076 89.80 Profit of 100 on sale
2024-11-18 SELL -664 88.220 89.840 89.678 USD -59,546 89.90 Profit of 149 on sale
2024-11-12 SELL -166 100.480 107.370 106.681 USD -17,709 89.20 Loss of -2,902 on sale
2024-11-07 SELL -166 99.160 99.480 99.448 USD -16,508 87.37 Loss of -2,006 on sale
2024-11-05 SELL -332 87.120 87.740 87.678 USD -29,109 86.88 Loss of -266 on sale
2024-10-28 SELL -166 84.990 86.330 86.196 USD -14,309 87.94 Profit of 290 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-10-24	SELL	-428	84.680	86.050	85.913	USD -36,771	71.51 Loss of -6,165 on sale
2025-09-11	BUY	215	77.680	77.690	77.689	USD 16,703	70.09
2025-07-08	SELL	-214	66.560	67.330	67.253	USD -14,392	70.11 Profit of 611 on sale
2025-06-24	SELL	-215	63.350	65.330	65.132	USD -14,003	70.40 Profit of 1,134 on sale
2025-06-23	SELL	-215	63.620	63.710	63.701	USD -13,696	70.45 Profit of 1,452 on sale
2025-06-20	BUY	9,577	63.000	64.640	64.476	USD 617,487	70.51
2025-06-11	SELL	-175	66.170	67.610	67.466	USD -11,807	70.82 Profit of 587 on sale
2025-05-30	SELL	-176	62.060	63.870	63.689	USD -11,209	71.18 Profit of 1,318 on sale
2025-05-21	BUY	176	65.540	69.840	69.410	USD 12,216	71.64
2025-05-14	SELL	-1,050	59.020	65.910	65.221	USD -68,482	72.09 Profit of 7,212 on sale
2025-04-30	SELL	-175	64.950	65.850	65.760	USD -11,508	73.31 Profit of 1,321 on sale
2025-04-28	SELL	-175	64.550	65.485	65.392	USD -11,444	73.48 Profit of 1,416 on sale
2025-04-25	SELL	-175	63.710	64.170	64.124	USD -11,222	73.58 Profit of 1,655 on sale
2025-04-11	SELL	-1,056	59.150	59.890	59.816	USD -63,166	74.61 Profit of 15,623 on sale
2025-04-08	SELL	-528	53.600	58.860	58.334	USD -30,800	75.24 Profit of 8,924 on sale
2025-04-07	BUY	850	56.650	60.170	59.818	USD 50,845	75.45
2025-03-31	SELL	-342	65.600	66.370	66.293	USD -22,672	76.06 Profit of 3,340 on sale
2025-03-21	SELL	-342	69.330	71.280	71.085	USD -24,311	76.53 Profit of 1,862 on sale
2025-03-12	SELL	-172	72.720	73.060	73.026	USD -12,560	77.03 Profit of 688 on sale
2025-02-28	SELL	-172	64.820	65.370	65.315	USD -11,234	78.25 Profit of 2,224 on sale
2025-02-25	BUY	172	62.650	63.630	63.532	USD 10,928	79.12
2025-02-20	SELL	-172	65.610	66.420	66.339	USD -11,410	79.94 Profit of 2,339 on sale
2025-02-19	BUY	344	63.290	64.585	64.455	USD 22,173	80.24
2025-02-18	BUY	172	64.255	67.000	66.725	USD 11,477	80.55
2024-12-30	BUY	749	78.350	79.120	79.043	USD 59,203	88.85
2024-12-06	SELL	-166	84.550	89.000	88.555	USD -14,700	89.41 Profit of 142 on sale
2024-12-04	SELL	-166	85.850	90.270	89.828	USD -14,911	89.65 Loss of -30 on sale
2024-12-03	SELL	-332	88.650	96.390	95.616	USD -31,745	89.68 Loss of -1,970 on sale
2024-11-21	SELL	-167	87.220	89.370	89.155	USD -14,889	89.55 Profit of 66 on sale
2024-11-20	SELL	-169	87.220	88.300	88.192	USD -14,904	89.68 Profit of 252 on sale
2024-11-19	SELL	-169	87.590	89.390	89.210	USD -15,076	89.80 Profit of 100 on sale
2024-11-18	SELL	-664	88.220	89.840	89.678	USD -59,546	89.90 Profit of 149 on sale
2024-11-12	SELL	-166	100.480	107.370	106.681	USD -17,709	89.20 Loss of -2,902 on sale
2024-11-07	SELL	-166	99.160	99.480	99.448	USD -16,508	87.37 Loss of -2,006 on sale
2024-11-05	SELL	-332	87.120	87.740	87.678	USD -29,109	86.88 Loss of -266 on sale
2024-10-28	SELL	-166	84.990	86.330	86.196	USD -14,309	87.94 Profit of 290 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of ACLX

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	57,382	0	85,442	67.2%
2025-09-18	72,084	100	212,754	33.9%
2025-09-17	93,493	0	217,316	43.0%
2025-09-16	63,059	0	97,222	64.9%
2025-09-15	79,004	1,990	113,437	69.6%
2025-09-12	192,535	200	262,834	73.3%
2025-09-11	142,225	3,100	357,968	39.7%
2025-09-10	86,053	0	127,794	67.3%
2025-09-09	45,204	0	82,469	54.8%
2025-09-08	80,096	0	110,076	72.8%
2025-09-05	44,424	3,000	86,551	51.3%
2025-09-04	62,712	0	106,523	58.9%
2025-09-03	57,834	100	92,688	62.4%
2025-09-02	130,934	3,506	201,626	64.9%
2025-08-29	103,044	35	138,240	74.5%
2025-08-28	77,971	14	2,001,030	3.9%
2025-08-27	46,732	0	62,928	74.3%
2025-08-26	44,364	63	72,593	61.1%
2025-08-25	99,008	0	139,417	71.0%
2025-08-22	86,554	61	128,945	67.1%
2025-08-21	104,626	0	130,107	80.4%
2025-08-20	99,170	0	157,388	63.0%
2025-08-19	102,393	0	158,658	64.5%
2025-08-18	117,593	6,114	195,452	60.2%
2025-08-15	128,484	6,858	171,869	74.8%
2025-08-14	135,480	7,131	189,431	71.5%
2025-08-13	224,050	35,129	543,993	41.2%
2025-08-12	147,345	56	183,453	80.3%
2025-08-11	119,057	0	172,468	69.0%
2025-08-08	303,743	1,455	361,985	83.9%
2025-08-07	252,566	0	341,948	73.9%
2025-08-06	158,609	0	192,524	82.4%
2025-08-05	65,345	976	147,834	44.2%
2025-08-04	45,920	0	70,589	65.1%
2025-08-01	54,368	120	76,693	70.9%
2025-07-31	78,939	13,959	113,608	69.5%
2025-07-30	242,772	100	302,674	80.2%
2025-07-29	101,826	0	149,984	67.9%
2025-07-28	99,801	0	128,094	77.9%
2025-07-25	79,547	100	125,958	63.2%
2025-07-24	101,045	6	150,771	67.0%
2025-07-23	99,387	0	351,453	28.3%
2025-07-22	319,261	0	437,751	72.9%
2025-07-21	67,833	0	81,531	83.2%
2025-07-18	127,033	0	195,007	65.1%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares Healthcare Innovation UCITS ETF USD (Acc)
Issuer	Blackrock
Entity holding fund	iShares IV Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300ZP07LMR36K1T02
ETF Ticker	DRDR(GBX) LSE
ETF Ticker	2B78(EUR) F
ETF Ticker	2B78.DE(EUR) CXE
ETF Ticker	DRDR.LS(GBX) CXE
ETF Ticker	HEAL.AS(EUR) CXE
ETF Ticker	HEAL.LS(USD) CXE
ETF Ticker	HEALz(USD) CXE
ETF Ticker	HEAL(EUR) ETF Plus
ETF Ticker	DRDR.L(GBP) LSE